LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 48.65 | 84.90 | 2066 | 5328 | 0.3877 | 0.7066 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 48.65 | 84.90 | 201 | 5328 | 0.0377 | 0.1553 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 48.65 | 84.90 | 2045 | 5328 | 0.3838 | 0.7037 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.36 | 84.90 | 1822 | 5651 | 0.3224 | 0.6591 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.36 | 84.90 | 1845 | 5651 | 0.3265 | 0.6625 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.36 | 84.90 | 2204 | 5651 | 0.3900 | 0.7120 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.36 | 84.90 | 2222 | 5651 | 0.3932 | 0.7143 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.36 | 84.90 | 236 | 5651 | 0.0418 | 0.1839 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.36 | 84.90 | 2154 | 5651 | 0.3812 | 0.7056 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.06 | 84.90 | 1728 | 5990 | 0.2884 | 0.6334 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.06 | 84.90 | 1755 | 5990 | 0.2930 | 0.6376 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.06 | 84.90 | 2372 | 5990 | 0.3959 | 0.7199 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.06 | 84.90 | 2391 | 5990 | 0.3991 | 0.7222 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.06 | 84.90 | 268 | 5990 | 0.0447 | 0.2059 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.06 | 84.90 | 2272 | 5990 | 0.3793 | 0.7079 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 84.90 | 2021 | 6252 | 0.3232 | 0.6671 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 84.90 | 2041 | 6252 | 0.3264 | 0.6697 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 84.90 | 2519 | 6252 | 0.4029 | 0.7273 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 84.90 | 2535 | 6252 | 0.4054 | 0.7291 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 84.90 | 282 | 6252 | 0.0451 | 0.2135 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 84.90 | 2387 | 6252 | 0.3818 | 0.7124 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 84.90 | 2146 | 6567 | 0.3267 | 0.6734 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 84.90 | 2162 | 6567 | 0.3292 | 0.6754 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 84.90 | 2664 | 6567 | 0.4056 | 0.7321 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 84.90 | 2687 | 6567 | 0.4091 | 0.7344 | MN20160318_Q02 | J05 |